4th Pharmacovigilance, Risk Management & AER Conference

The 4th Pharmacovigilance, Risk Management & AER Conference will address many pressing concerns regarding drug safety, including effectively identifying and managing potential risks and ensuring a balanced benefit-risk ratio. Top pharmaceutical and biotech representatives will discuss the current complexities and key challenges in pharmacovigilance and risk management throughout the product lifecycle.

By attending this conference, delegates will gain a comprehensive understanding of the challenges being faced by professionals working in pharmacovigilance. They will learn how regulatory shifts have impacted risk management and safety surveillance strategies as part of their post-market pharmacovigilance practice.

Hot topics, such as the use of social media in signal detection and the role of pharmacovigilance across the product lifecycle will be discussed as well. In addition, attendees will have the opportunity to engage in meaningful  conversations with their peers who are dealing with many of the same issues involved with pharmacovigilance, risk management, and adverse event reporting.

Key Topics

• Determine the impact regulatory shifts have had on the industry’s pharmacovigilance, risk, and adverse event reporting practices
• Design risk-benefit analysis tools to enhance internal Risk Evaluation and Mitigations Strategy (REMS) reporting capabilities
• Leverage proven risk management strategies to enhance international compliance capabilities
• Implement risk management and safety surveillance strategies into day-to-day processes to create a comprehensive post-market pharmacovigilance practice
• Utilize pharmacovigilance databases to facilitate the generation and detection of safety signals

Contact: Tyler Kelch, Marketing & PR Coordinator | E: tylerke@marcusevansch.com | P:312.894.6377

Click Here to view Event Website and for more info